According to the recent announcement by Lumen XT, Marc Beer is the new Board Chairman. Lumen XT is a private company and specialized in advancing surgical lines of surgical products. The focus of these developments is to reduce the invasiveness of surgeries. They intend to use LED illumination which is essential for purposes of intracavity. Through advanced visualization, they use the illumination platform of the company for safety improvement.
According to surgeons with knowledge about illumination, the technology is one of the best when it comes to the enhancement of visualization, precision and flexibility during surgeries. Lumen XT provides illumination platform which is crucial for the mechanism of reducing heat. They want to improve it for a disposable option which is not costly. The idea is also to improve safety and precision during operations. Marc Beer has shed light on his role in the great organization.
Marc said it is a privilege to work with Lumen XT and he is proud to work for the company and bring the best. The talented leader says that the firm has accomplished and dedicated engineers and surgeons. It is incredible to work with these professionals who try to use the organization’s technology to improve the surgical illumination field. The brilliant Chairman of the board for the company says the platform is crucial because today minimally invasive ways are used to perform surgeries.
One of the founders of the company is Paul Rhyne, and he was happy to comment about Marc Beer. Talking about the appointment of Beer, he said the leader is one of the best in the industry because of the demonstration of great success in various startup companies. Beer has managed to grow different firms in their various growth phases. Rhyne pointed out that Beer is not only excellent in running a company, but he also has experience when it comes to guiding firms to achieve their missions. Paul believes that Beer would use his expertise for the benefit of the company.
Marc Beer is the perfect individual to take the new role as the new Chairman of the Board. With more than twenty years in the industry, he has what it takes to commercialize and develop companies in different sectors like diagnostics, pharmaceuticals, biotechnology and devices. Apart from working for Lumen XT as the new Chairman of the Board, Marc is one of the founders of Renovia where he also serves as the CEO. The company which started in 2016 has been specializing in the delivery of diagnostic devices and digital therapeutic devices to individuals who have some disorders like pelvic floor. For many years, he has worked for many companies, his career has been successful, and many admire his boldness in running organizations successfully. With his experience, Beer is taking Lumen XT to the next level of achievement. Learn more: https://renoviainc.com/
Marc Beer is a successful businessman who heads the Renovia Inc. startup company as the CEO and co-founder. The company is set to launch a diverse number of new products that will be used in the treatment of pelvic floor disorder after it managed to raise a total of $42 million through Beer’s efforts. Renovia Inc. which is based in Boston seeks to develop a variety of the said products to be used in diagnostic and therapeutic procedures in pelvic floor disorder treatments in cases such as urinary incontinence among others. What’s more, with the launch of the new products will see the treatment of the pelvic floor disorders being of benefit to an estimated number of more than 250 million women in the world. Equally important, one of Renovia’s pioneer products known as Leva has already been approved by the FDA.
Further, the Long Wood Fund, an investment firm that specializes in the health sector is also part of the Series B round where it was preceded by the Perceptive Advisors Organization in New York and Ascension Ventures in Missouri. Furthermore, the funds collected will go a long way in the creation and development of four other diagnostic and therapeutic products that will include an improved Leva device. Marc Beer, the CEO of the Renovia said in a statement that the company was delighted to have some of the top healthcare investors supporting them besides sharing their vision of forming solutions for women with pelvic floor disorders. He added that with the teaming up of the given organizations, would stir innovation and technologies to help establish better digital platforms essential during the treatment options. Moreover, the new technologies will ultimately increase more information and understating in dealing with pelvic floor disorders and the general lowering of health costs.
About Marc Beer’s Career
As one of the respected businessman supporting a vital section in women’s health, Marc Beer has served in various capacities in the healthcare sector that include diagnostic, biotechnology and pharmaceutical industries. Also, with over 25 years of experience in the healthcare market place, his main are area of specialization has been in the development and commercialization of the above digital healthcare platforms. Having worked in several other companies, his latest achievement is when he co-founded Renovia alongside his partners Yolanda Lorie and Ramon Iglesias, who is the MD of the firm in 2016. Notably, it was shortly after starting the company, that Renovia Inc. began by closing the Series A financing when they combined efforts with some of the top healthcare ventures in the market. Other than that, Marc Beer has been in the frontline of making discoveries in the healthcare industry where such an example is when he was responsible for marketing JUXTAPID drug that received approval in more than 30 counties. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html
Marc Beer is a well-accomplished individual that has currently taken to biotech and pharmaceutical pursuits. Just two years ago, Marc Beer started off the company Renovia along with two colleagues of his, which is focused on research and developing treatments for women all over the world. In the latest series of funding conducted by Marc Beer at Renovia, they managed to get more than 40 million dollars to go towards new research and the development of new treatments for pelvic floor disorders, which currently afflicts more than 250 million women across the world. Marc Beer is dedicated to his mission to help people around the world through his knowledge and discovery and Renovia is his first true legitimate display of that.
The funding for Renovia has come from various sources since the company first started up, though in the last series of funding the majority of the money came from investors that want to help the healthcare industry. Roughly 10 million dollars of funding came from debt financing as part of the deal. Various other healthcare organizations have expressed interest and invested in Renovia since it first started, including OSF Ventures, Longwood Fund, Western Technology Investment, and Ascension Ventures. Renovia is currently based out of Boston in the United States and in the past two years since it first started, it has gained tremendous traction throughout the region.
Since 2016, Renovia has managed to get the approval of one drug for treating pelvic floor disorders in women known as Leva. The FDA approved this drug without any hassle at all and it will be the first line for treating women with pelvic floor disorders. Leva also uses technology to check urinary tissues inside of the body to see what kind of responses they have normally and with the drug.
Marc beer is more than Renovia’s founder, he is also the current Chief Executive Officer and chairman of the board at the company. Marc has spent more than two decades moving in an out of the biotech industry, focusing on development, research, commercialization, and more. On top of his successful career as an entrepreneur, businessman, and healthcare enthusiast, Marc is a dedicated husband and father. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing